Table 3 of
Urbančič, Mol Vis 2020; 26:472-482. Table 3 of
Urbančič, Mol Vis 2020; 26:472-482.
Table 3. Comparison of samples from patients with PDR and patients with MH – median (minimum-maximum); Mann–Whitney test.
| Cytokine | vitreous | serum | ||||
|---|---|---|---|---|---|---|
| PDR (n=33) | MH (n=20) | P value | PDR (n=33) | MH (n=20) | P value | |
| MCP-1 (pg/ml) | 1614.98 (403.05–3990.74) | 374.17 (295.01–881.87) | 0.0001 | 72.6 (25.06–169.65) | 43.4 (30.24–76.64) | 0.02 |
| IL-8 (pg/ml) | 93.29 (20.04–295.71) | 14.49 (13.12–16.64) | 0.0001 | 11.99 (10.12–31.69) | 12.71 (11.21–13.33) | 0.84 |
| IL-6 (pg/ml) | 60.82 (13.64–798.23) | 6 (5.28–8.1) | 0.0001 | 5.46 (2.41–24.76) | 9.14 (5.81–298.4) | 0.02 |
| VEGF (pg/ml) | 304.64 (26.41–1439.3) | 4.58 (3.5–31.79) | 0.0001 | 38.66 (6.17–105.56) | 25.73 (17.62–63.61) | 0.55 |
| IL-1β (pg/ml) | 9.15 (7.51–67.36) | 10.5 (7.7–35.99) | 0.51 | 7.6 (6.91–15.16) | 7.7 (7.11–95.55) | 0.55 |
| TNF-α (pg/ml) | 13.41 (3.26–69.09) | 21.5 (5.16–38.4) | 0.25 | 5.7 (2.9–23.35) | 4.79 (4,0–98.76) | 0.82 |
| MIP-1α (pg/ml) | 9.55 (6.9–68.26) | 14.25 (9.76–47.34) | 0.004 | 15.07 (7.78–91.74) | 20.38 (11.83–91.07) | 0.27 |
| MIP-1β (pg/ml) | 12.09 (2.9–38.02) | 13.44 (0.9–14.4) | 0.31 | 18.76 (6.89–48.83) | 17.72 (15.51–60.5) | 0.80 |
| IL-10 (pg/ml) | 5.67 (4.9–8.12) | 6.05 (5.84–6.08) | 0.02 | 7.4 (5.3–15.28) | 6.63 (5.7–58.43) | 0.67 |
| IL-12 (pg/ml) | 3.17 (0.68–22.26) | 3.99 (2.56–11.18) | 0.04 | 17.7 (2.49–42.91) | 18.84 (7.09–71.71) | 0.25 |